The short-acting GLP-1 receptor agonists primarily lower postprandial blood glucose levels through inhibition of gastric emptying, whereas the long-acting compounds have a stronger effect on fasting glucose levels, which is mediated predominantly through their insulinotropic and glucagonostatic actions
IL-6 is both a pro- and an anti-inflammatory factor in many biological processes
If you are looking for broader support in this area, the Energy & Focus collection is a natural next stop
NNMTi-treatment offers a promising therapeutic approach to address this unmet need 8,9,13
When speaking with your doctor, it may be helpful to: Share your weight management history , including previous treatments, lifestyle interventions, and any underlying conditions such as type 2 diabetes, hypertension, or sleep apnoea Ask about currently approved options , such as orlistat (available on the NHS